{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:59:42Z","timestamp":1790258382526,"version":"4.1.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","funder":[{"name":"Charlies Foundation for Research","award":["MRGP21-22_24"],"award-info":[{"award-number":["MRGP21-22_24"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Immunosuppressive drugs have been used in transplantation for decades; however, their impact on donor and recipient leukocyte dynamics after transplantation have not been well defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>Murine mismatched kidney transplants were exposed to tacrolimus, mycophenolate, methylprednisolone, abatacept, and T-cell depletion therapy. Drug dosing was determined by pharmacokinetic analysis to mimic therapeutic levels of human kidney recipients. Donor and recipient leukocytes of 19 subsets, isolated from the graft and periphery after kidney transplantation in the presence of monotherapy or combination immunosuppression, were examined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>Immunosuppression significantly reduced recipient leukocyte infiltration into the graft. Additionally, methylprednisolone reduced peripheral leukocyte counts, while mycophenolate had a moderate effect. Tacrolimus was most immunosuppressive, reducing day 7 graft histological rejection scores, inducing changes in graft donor and recipient macrophage phenotypes, reducing T-cell co-inhibitory receptor and granzyme B expression, and peripheral leukocyte counts. Combination therapy with tacrolimus, mycophenolate, and methylprednisolone displayed an additive immunosuppressive effect. Despite these significant changes to recipient leukocyte immunity, the impact of conventional immunosuppressive agents on donor leukocyte retention was modest.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>These data confirm the critical importance of tacrolimus in preventing acute graft rejection. We demonstrate that conventional immunosuppressive strategies do not contribute to substantial donor leukocyte maintenance in grafted kidneys despite impairing recipient immunity, highlighting the need for alternative approaches to preserve beneficial donor immunity after kidney transplantation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000005840","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T18:06:27Z","timestamp":1784570787000},"page":"e2057-e2071","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Common Immunosuppressants Impair Recipient Immunity but do not Safeguard Donor Tissue-resident Immunity in Kidney Transplantation"],"prefix":"10.1097","volume":"110","author":[{"given":"Sarah J.","family":"Dart","sequence":"first","affiliation":[{"name":"Medical School, The University of Western Australia, Perth, WA, Australia."},{"name":"Department of Ophthalmology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Prosser","sequence":"additional","affiliation":[{"name":"Medical School, The University of Western Australia, Perth, WA, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Liu","sequence":"additional","affiliation":[{"name":"Medical School, The University of Western Australia, Perth, WA, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaskirat","family":"Kaur","sequence":"additional","affiliation":[{"name":"Medical School, The University of Western Australia, Perth, WA, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Medical School, The University of Western Australia, Perth, WA, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean J.","family":"O\u2019Halloran","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Clinical Pharmacology and Toxicology, Pathwest Laboratory Medicine, QEII Medical Centre, Perth, WA, Australia."},{"name":"School of Biomedical Sciences, The University of Western Australia, Perth, WA, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Special Chemistry, PathWest Laboratory Medicine, Sir Charles Gardiner Hospital, Perth, WA, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette K.","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, QEII Medical Centre, Pathwest Laboratory Medicine, Perth, WA, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella L.","family":"Trolio","sequence":"additional","affiliation":[{"name":"Medical School, The University of Western Australia, Perth, WA, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Madore","sequence":"additional","affiliation":[{"name":"Sydney Cytometry Core Research Facility, University of Sydney, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Hua","family":"Huang","sequence":"additional","affiliation":[{"name":"Medical School, The University of Western Australia, Perth, WA, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka K.","family":"Pindoria","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Clinical Pharmacology and Toxicology, Pathwest Laboratory Medicine, QEII Medical Centre, Perth, WA, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francina","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology (Core Biochemistry), Sir Charles Gairdner Hospital, Pathwest Laboratory Medicine, Perth, WA, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Lucas","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, The University of Western Australia, Perth, WA, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary P.","family":"Jeffrey","sequence":"additional","affiliation":[{"name":"Medical School, The University of Western Australia, Perth, WA, Australia."},{"name":"Department of Hepatology, Sir Charles Gairdner Hospital, Perth, WA, Australia."},{"name":"Western Australian Liver Transplant Service, Sir Charles Gairdner Hospital, Perth, WA, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Joyce","sequence":"additional","affiliation":[{"name":"Medical School, The University of Western Australia, Perth, WA, Australia."},{"name":"Department of Clinical Biochemistry, Clinical Pharmacology and Toxicology, Pathwest Laboratory Medicine, QEII Medical Centre, Perth, WA, Australia."},{"name":"School of Biomedical Sciences, The University of Western Australia, Perth, WA, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Lucas","sequence":"additional","affiliation":[{"name":"Medical School, The University of Western Australia, Perth, WA, Australia."},{"name":"Department of Immunology, Sir Charles Gairdner Hospital, PathWest Laboratory Medicine, Perth, WA, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"R1-20260924","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1097\/TP.0000000000004481","article-title":"Subset-specific retention of donor myeloid cells after major histocompatibility complex-matched and mismatched liver transplantation.","volume":"107","author":"Dart","year":"2023","journal-title":"Transplantation"},{"key":"R2-20260924","doi-asserted-by":"crossref","first-page":"109141","DOI":"10.1016\/j.celrep.2021.109141","article-title":"Dynamic changes to tissue-resident immunity after MHC-matched and MHC-mismatched solid organ transplantation.","volume":"35","author":"Prosser","year":"2021","journal-title":"Cell Rep"},{"key":"R3-20260924","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00428-003-0861-8","article-title":"The role of graft-resident Kupffer cells and lymphocytes of donor type during the time course after liver transplantation? A clinico-pathological study.","volume":"443","author":"Bittmann","year":"2003","journal-title":"Virchows Arch"},{"key":"R4-20260924","doi-asserted-by":"crossref","first-page":"e20200050","DOI":"10.1084\/jem.20200050","article-title":"Longevity and replenishment of human liver-resident memory T cells and mononuclear phagocytes.","volume":"217","author":"Pallett","year":"2020","journal-title":"J Exp Med"},{"key":"R5-20260924","doi-asserted-by":"crossref","first-page":"5984","DOI":"10.1038\/s41598-019-42401-9","article-title":"Characterization of donor and recipient CD8+ tissue-resident memory T cells in transplant nephrectomies.","volume":"9","author":"de Leur","year":"2019","journal-title":"Sci Rep"},{"key":"R6-20260924","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1681\/ASN.2020030326","article-title":"Harnessing expressed single nucleotide variation and single cell RNA sequencing to define immune cell chimerism in the rejecting kidney transplant.","volume":"31","author":"Malone","year":"2020","journal-title":"JASN"},{"key":"R7-20260924","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1038\/s41467-023-39859-7","article-title":"Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection.","volume":"14","author":"Lamarth\u00e9e","year":"2023","journal-title":"Nat Commun"},{"key":"R8-20260924","doi-asserted-by":"crossref","first-page":"eaav5581","DOI":"10.1126\/sciimmunol.aav5581","article-title":"Generation and persistence of human tissue-resident memory T cells in lung transplantation.","volume":"4","author":"Snyder","year":"2019","journal-title":"Sci Immunol"},{"key":"R9-20260924","doi-asserted-by":"crossref","first-page":"eaah3732","DOI":"10.1126\/sciimmunol.aah3732","article-title":"Bidirectional intragraft alloreactivity drives the repopulation of human intestinal allografts and correlates with clinical outcome.","volume":"1","author":"Zuber","year":"2016","journal-title":"Sci Immunol"},{"key":"R10-20260924","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/hep.1840170629","article-title":"Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance.","volume":"17","author":"Starzl","year":"1993","journal-title":"Hepatology"},{"key":"R11-20260924","doi-asserted-by":"crossref","first-page":"6471901","DOI":"10.1155\/2016\/6471901","article-title":"Combined bone marrow and kidney transplantation for the induction of specific tolerance.","volume":"2016","author":"Chen","year":"2016","journal-title":"Adv Hematol"},{"key":"R12-20260924","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/TP.0b013e31820a3068","article-title":"Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease.","volume":"91","author":"Spitzer","year":"2011","journal-title":"Transplantation"},{"key":"R13-20260924","doi-asserted-by":"crossref","first-page":"127215","DOI":"10.1155\/2012\/127215","article-title":"A knotless technique for kidney transplantation in the mouse.","volume":"2012","author":"Rong","year":"2012","journal-title":"J Transplant"},{"key":"R14-20260924","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1111\/j.1600-6143.2012.04213.x","article-title":"Induction of allograft tolerance by monoclonal CD3 antibodies: a matter of timing.","volume":"12","author":"You","year":"2012","journal-title":"Am J Transplant"},{"key":"R15-20260924","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/ajt.15898","article-title":"The Banff 2019 kidney meeting report (I): updates on and clarification of criteria for T cell- and antibody-mediated rejection.","volume":"20","author":"Loupy","year":"2020","journal-title":"Am J Transplant"},{"key":"R16-20260924","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","article-title":"Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report.","volume":"41","author":"Brunet","year":"2019","journal-title":"Ther Drug Monit"},{"issue":"Suppl 3","key":"R17-20260924","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients.","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"R18-20260924","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s40262-015-0282-2","article-title":"Clinical pharmacokinetics of once-daily tacrolimus in solid-organ transplant patients.","volume":"54","author":"Staatz","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"R19-20260924","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0009-9120(98)00040-X","article-title":"Therapeutic monitoring of mycophenolic acid. A consensus panel report.","volume":"31","author":"Shaw","year":"1998","journal-title":"Clin Biochem"},{"key":"R20-20260924","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s40262-012-0007-8","article-title":"Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation.","volume":"51","author":"Bergmann","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"R21-20260924","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1710-1492-9-30","article-title":"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy.","volume":"9","author":"Liu","year":"2013","journal-title":"All Asth Clin Immun"},{"key":"R22-20260924","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2125.1997.00586.x","article-title":"Suppression of human monocyte tumour necrosis factor-alpha release by glucocorticoid therapy: relationship to systemic monocytopaenia and cortisol suppression.","volume":"43","author":"Steer","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"R23-20260924","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00007691-200002000-00003","article-title":"Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation.","volume":"22","author":"Shaw","year":"2000","journal-title":"Ther Drug Monit"},{"key":"R24-20260924","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/FTD.0000000000000871","article-title":"Personalized therapy for mycophenolate: consensus report by the international association of therapeutic drug monitoring and clinical toxicology.","volume":"43","author":"Bergan","year":"2021","journal-title":"Ther Drug Monit"},{"key":"R25-20260924","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/aps.2009.13","article-title":"Pharmacokinetics of CTLA4Ig fusion protein in healthy volunteers and patients with rheumatoid arthritis.","volume":"30","author":"Ma","year":"2009","journal-title":"Acta Pharmacol Sin"},{"key":"R26-20260924","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1021\/js950428+","article-title":"A pharmacokinetic study of intravenous CTLA4Ig, a novel immunosuppressive agent, in mice.","volume":"85","author":"Srinivas","year":"1996","journal-title":"J Pharm Sci"},{"key":"R27-20260924","doi-asserted-by":"crossref","first-page":"e45312","DOI":"10.1371\/journal.pone.0045312","article-title":"A pilot study to examine the effect of chronic treatment with immunosuppressive drugs on mucociliary clearance in a vagotomized murine model.","volume":"7","author":"Bhashyam","year":"2012","journal-title":"PLoS One"},{"key":"R28-20260924","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1111\/ajt.17038","article-title":"T cell depletion increases humoral response by favoring T follicular helper cells expansion.","volume":"22","author":"Gassen","year":"2022","journal-title":"Am J Transplant"},{"key":"R29-20260924","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3760\/cma.j.issn.0366-6999.20121542","article-title":"Mycophenolate mofetil affects monocyte Toll-like receptor 4 signaling during mouse renal ischemia\/reperfusion injury.","volume":"126","author":"Zhang","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"R30-20260924","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/01.tp.0000226227.79142.31","article-title":"Combination effect of mycophenolate mofetil with mizoribine on cell proliferation assays and in a mouse heart transplantation model.","volume":"82","author":"Shimmura","year":"2006","journal-title":"Transplantation"},{"key":"R31-20260924","doi-asserted-by":"crossref","first-page":"e13203","DOI":"10.1111\/sji.13203","article-title":"Novel immunosuppressive effect of FK506 by upregulation of PD-L1 via FKBP51 in heart transplantation.","volume":"96","author":"Luo","year":"2022","journal-title":"Scand J Immunol"},{"key":"R32-20260924","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1007\/s11748-022-01844-0","article-title":"Antibodies against complement component C5 prevent antibody-mediated rejection after lung transplantation in murine orthotopic models with skin-graft-induced pre-sensitization.","volume":"70","author":"Shiina","year":"2022","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"R33-20260924","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00007691-199512000-00007","article-title":"Mode of action of tacrolimus (FK506): molecular and cellular mechanisms.","volume":"17","author":"Thomson","year":"1995","journal-title":"Ther Drug Monit"},{"key":"R34-20260924","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/tri.13390","article-title":"Evaluation of the impact of conventional immunosuppressant on the establishment of murine transplantation tolerance\u2014an experimental study.","volume":"32","author":"Katsumata","year":"2019","journal-title":"Transpl Int"},{"key":"R35-20260924","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1681\/ASN.2009060615","article-title":"Distinct macrophage phenotypes contribute to kidney injury and repair.","volume":"22","author":"Lee","year":"2011","journal-title":"JASN"},{"key":"R36-20260924","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1160\/TH09-07-0502","article-title":"Low- but not high-dose FK506 treatment confers atheroprotection due to alternative macrophage activation and unaffected cholesterol levels.","volume":"104","author":"Bai","year":"2010","journal-title":"Thromb Haemost"},{"key":"R37-20260924","doi-asserted-by":"crossref","first-page":"e0170806","DOI":"10.1371\/journal.pone.0170806","article-title":"The effect of tacrolimus and mycophenolic acid on CD14+ monocyte activation and function.","volume":"12","author":"Kannegieter","year":"2017","journal-title":"PLoS One"},{"key":"R38-20260924","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2353\/ajpath.2006.050360","article-title":"Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection.","volume":"168","author":"Lin","year":"2006","journal-title":"Am J Pathol"},{"key":"R39-20260924","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1111\/ajt.15319","article-title":"Abatacept as rescue immunosuppression after calcineurin inhibitor treatment failure in renal transplantation.","volume":"19","author":"Badell","year":"2019","journal-title":"Am J Transplant"},{"key":"R40-20260924","doi-asserted-by":"crossref","first-page":"10681","DOI":"10.3389\/ti.2022.10681","article-title":"Abatacept rescue therapy in kidney transplant recipients: a case series of five patients.","volume":"35","author":"Uro-Coste","year":"2022","journal-title":"Transpl Int"},{"key":"R41-20260924","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature17655","article-title":"Normalizing the environment recapitulates adult human immune traits in laboratory mice.","volume":"532","author":"Beura","year":"2016","journal-title":"Nature"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005840","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:05:49Z","timestamp":1790255149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005840","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]}}}